Advertisement

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME

About the Journal
Editorial Board & Staff

About JACC CME
Hardware/Software Requirements
Contact Us
Policy on Privacy and Confidentiality
Copyright Information

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

Click here for more guidelines.
2009 Focused Updates: ACC/AHA Guidelines for STEMI and ACC/AHA/SCAI Guidelines for PCI
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
ACC 2009 Advocacy Position Statement: Principles for Comparative Effectiveness Research
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:1033-1039, doi:10.1016/j.jacc.2007.10.055
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basavarajaiah, S.
Right arrow Articles by Sharma, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Basavarajaiah, S.
Right arrow Articles by Sharma, S.
Related Collections
Right arrowRelated Article

Prevalence of Hypertrophic Cardiomyopathy in Highly Trained Athletes

Relevance to Pre-Participation Screening

Sandeep Basavarajaiah, MBBS, MRCP*,{dagger}, Matthew Wilson, MSc, MPhil{ddagger}, Gregory Whyte, PhD{ddagger}, Ajay Shah, PhD, FRCP*, William McKenna, DSc, FRCP, FESC, FACC§ and Sanjay Sharma, BSc (Hons), MD, FRCP*,{dagger},*

* King’s College Hospital, London, England
{dagger} University Hospital, London, England
{ddagger} Olympic Medical Institute, London, England
§ The Heart Hospital, London, England.


Figure 1
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 Distribution of LVWT in 3,500 Elite Athletes

We found that 1.5% of elite athletes showed a wall thickness >12 mm. LVWT = left ventricular wall thickness.

 

Figure 2
View larger version (134K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 Electrocardiograms and Parasternal Short-Axis Views of the LV at the Level of Papillary Muscle of the 3 Athletes With LVH and a Nondilated LV Cavity

All 3 athletes showed left ventricular hypertrophy (LVH) associated with a nondilated left ventricular (LV) cavity and inferior and lateral leads.

 

Figure 3
View larger version (50K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 3 Electrocardiograms of a Swimmer With LVH and Inferolateral T-Wave Inversions Before and After Detraining for 12 Weeks

Detraining was associated with regression of left ventricular hypertrophy (LVH) on echocardiography and normalization of deep T-wave inversions after detraining.

 
 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement